Tizanidne Hydrochloride Capsule
Product Images NDC 71335-2210

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 71335-2210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Lbl713352210)

Label (Lbl713352210)
This is a description of a medication called Tizanidine Hydrochloride Capsules. Each capsule contains 6.87 mg of Tizanidine (equivalent to 6 mg of Tizanidine base). It is important to keep this medication out of the reach of children and store it at a temperature between 15°C to 30°C (59°F to 86°F) according to USP Controlled Room Temperature guidelines. The medication should be dispensed in tight containers with child-resistant closure. It is worth noting that these capsules are not interchangeable with Tizanidine tablets or Zanaflex® tablets. The product is available in a packaging of 150 capsules, manufactured by Alkem Laboratories Ltd and relabeled by Bryant Ranch Prepack, Inc. It is only available with a prescription from a healthcare professional.*
FDA Label Image

Tiz01 (Tiz01)

Tiz01 (Tiz01)
FDA Label Image

Tiz02 (Tiz02)

Tiz02 (Tiz02)
FDA Label Image

Tiz03 (Tiz03)

Tiz03 (Tiz03)
FDA Label Image

Tiz04 (Tiz04)

Tiz04 (Tiz04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.